GLOBAL BIO-CHEM (00809) appoints Xiao Zexian as Executive Director and Chairman of the Board.
Dacheng Biotechnology (00809) announced that, effective August 19, 2026, Mr. Wang Cheng has resigned as an executive director and will no longer serve as the chairman of the board, chairman of the nomination committee, member of the executive committee, member of the compensation committee, and member of the corporate governance committee, as well as the authorized representative of the company under Rule 3.05 of the Listing Rules; Mr. Xiao Zexian has been appointed as an executive director, chairman of the board, chairman of the nomination committee, member of the executive committee, member of the compensation committee, and member of the corporate governance committee.

5 h ago
SICC Co., Ltd. (02631) reported a 15.1% year-on-year growth in mid-term operating revenue to 914 million yuan, focusing on ramping up large-sized products and driving the continuous optimization and upgrade of product structure.
TianYue Advanced (02631) announced its performance for the six months ended June 30, 2026, with operating revenue of 914 million yuan, a year-on-year increase of 15.10%, and a comprehensive gross margin of 22.86%. As the new energy vehicle industry accelerates its transition to high-voltage platforms and AI computing infrastructure continues to expand, the value of silicon carbide in downstream applications is becoming increasingly prominent, with market penetration steadily rising. During the reporting period, the company's product output and sales grew steadily, achieving both year-on-year and quarter-on-quarter revenue growth; leveraging its market-leading advantage in large-sized silicon carbide substrates, along with ongoing cost reduction and efficiency improvement measures, and supported by recovering downstream demand which stabilized product prices, the company improved its gross margin level.

5 h ago